This page lists all known medications that could potentially lead to 'Lymphangioleiomyomatosis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Eligible patients had one or more renal angiomyolipomas that were more than 2 cm in the longest diameter on magnetic resonance imaging (MRI). The study was approved by a U.K. multicenter research ...

The case: A 48-year-old woman visited her family physician because of gradual-onset dyspnea, fatigue and an occasional cough. Dyspnea occurred when the patient walked up stairs, in the cold or against ...

Lymphangioleiomyomatosis, a rare lung disease typically affecting women of reproductive age, is characterized by an abnormal proliferation of smooth-muscle cells and the progressive loss of pulmonary ...

Lymphangioleiomyomatosis is a rare and progressive lung cystic disease, caused by the infiltration of lung parenchyma by mesenchymal cells characterized by co-expression of contractile proteins and ...

Further use of progestins as treatment for women with immunologic diseases, which could have occurred because of previous progestin use, could be one reason for a high 10-year mortality in LAM.

A rare and potentially deadly lung disease called Lymphangioleiomyomatosis (LAM) strikes women during their childbearing years. Symptoms of the debilitating disease, which almost exclusively affects ...

This study was approved by the Institutional Review Board of Fox Chase Cancer Center. Paraffin-embedded tissue sections, 4 μm, were used for immunohistochemical analysis; 10 μm sections were used for ...

A treatment for a rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers. Science X Daily and the Weekly Email Newsletter are ...